Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NOXXON Pharma NV (DE:0N6A)
FRANKFURT:0N6A
Holding DE:0N6A?
Track your performance easily
0N6A Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.00 - €0.31
Previous CloseN/A
Volume0.00
Average Volume (3M)2.60K
Market Cap
€7.07M
Enterprise Value€1.52M
Total Cash (Recent Filing)$2.37M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Apr 23, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding94,185,850
10 Day Avg. Volume2,111
30 Day Avg. Volume2,603
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)200.59
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.21
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
0N6A FAQ
What was NOXXON Pharma NV’s price range in the past 12 months?
NOXXON Pharma NV lowest stock price was €0.00 and its highest was €0.31 in the past 12 months.
What is NOXXON Pharma NV’s market cap?
NOXXON Pharma NV’s market cap is €7.07M.
When is NOXXON Pharma NV’s upcoming earnings report date?
NOXXON Pharma NV’s upcoming earnings report date is Apr 23, 2025 which is in 98 days.
How were NOXXON Pharma NV’s earnings last quarter?
NOXXON Pharma NV released its earnings results on Oct 18, 2024. The company reported -€0.089 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.089.
Is NOXXON Pharma NV overvalued?
According to Wall Street analysts NOXXON Pharma NV’s price is currently Overvalued.
Does NOXXON Pharma NV pay dividends?
NOXXON Pharma NV does not currently pay dividends.
What is NOXXON Pharma NV’s EPS estimate?
NOXXON Pharma NV’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NOXXON Pharma NV have?
NOXXON Pharma NV has 94,185,850 shares outstanding.
What happened to NOXXON Pharma NV’s price movement after its last earnings report?
NOXXON Pharma NV reported an EPS of -€0.089 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of NOXXON Pharma NV?
Currently, no hedge funds are holding shares in DE:0N6A
---
Company Description
NOXXON Pharma NV
NOXXON Pharma NV is a clinical-stage biopharmaceutical company engaged in improving cancer treatment by targeting the tumor microenvironment. All its product candidates are based on a new class of drug called Spiegelmers, which are identified and synthesized through a proprietary discovery platform which the Group believes offers specific advantages over other drug classes. All operational activities are conducted in Berlin.
---
Technical Analysis
---